NCT05504525

Brief Summary

Postoperative analgesia is essential for early ambulation of patients with hip arthroplasties as well as decreasing hospital stay time. Fascial plane blocks are emerging as a gold standard for postoperative analgesia instead of opioids and NSAIDs, with all there side effects. The investigators aim to compare postoperative pain levels and opioid analgesic needs of fascia iliaca block versus quadratus lumborum block in patients undergoing primary total hip arthroplasty under general anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2022

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 17, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 3, 2022

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

January 20, 2023

Status Verified

January 1, 2023

Enrollment Period

6 months

First QC Date

June 4, 2022

Last Update Submit

January 19, 2023

Conditions

Keywords

opioid requirements

Outcome Measures

Primary Outcomes (1)

  • Duration of postoperative analgesia

    The investigators will measure the time to first analgesic request after giving the block

    24 hours

Secondary Outcomes (2)

  • Total rescue analgesic requirements

    24 hours

  • Functional recovery

    72 hours

Study Arms (2)

Fascia iliaca block for postoperative pain management in hip arthroplasty

ACTIVE COMPARATOR
Procedure: Fascia Iliaca block

Quadratus lumborum block for postoperative pain management in hip arthroplasty

ACTIVE COMPARATOR
Procedure: Quadratus lumborum block

Interventions

Ultrasound guided fascia iliaca block done by palpation of anterior superior iliac spine to identify the inguinal crease, then place the ultrasound probe on it to identify the sartorius muscle. Sonographic anatomy will be identified, from superficial to deep, consisting of subcutaneous fat, the internal oblique muscle, the transverse abdominis muscle, the fascia iliaca covering the iliacus muscle and the iliacus muscle itself. The block needle will be advanced in out-of plane to puncture the fascia iliaca. With the needle tip just below the fascia iliaca, 2 ml of a local anesthetic will be injected to confirm the tip location. Once the proper position is confirmed, 40 ml of bupivacaine 0.25% will be injected superficial to the iliacus muscle and deep to the fascia iliaca.

Fascia iliaca block for postoperative pain management in hip arthroplasty

The patients will receive anterior ultrasound guided quadratus lumborum block QLB in the lateral position. The transducer will be first placed in a parasagittal orientation 3-4 cm lateral to the midline and over the sacrum to identify the L5 transverse process. The probe will then rotated into a transverse orientation with slight medial and caudal angulation to obtain a transverse oblique view at L5 transverse process .The ultrasound probe will be tilted , so the lateral end of the probe will be more cranial than the medial side of the probe to avoid the acoustic shadow of the iliac crest. Identify the quadratus lumborum and psoas major and inject the local anesthetic above the QL

Quadratus lumborum block for postoperative pain management in hip arthroplasty

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All patients aging between 40-60 years ASA II, III with no known hypersensitivity for local anesthetics

You may not qualify if:

  • Patient refusal
  • Known allergy to local anesthetics
  • Previous femoral artery surgery
  • Local infection at the site of injection
  • Those on anticoagulation therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams university hospitals

Cairo, 11566, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 4, 2022

First Posted

August 17, 2022

Study Start

May 30, 2022

Primary Completion

December 3, 2022

Study Completion

December 30, 2022

Last Updated

January 20, 2023

Record last verified: 2023-01

Locations